Results 1 to 10 of about 16,784 (161)

EAR-20 peptide, a novel NMDA receptor positive allosteric modulator [PDF]

open access: yesFrontiers in Pharmacology
Allosteric modulation of ligand-gated ion channels provides a powerful mechanism to fine-tune their activity without competing with endogenous ligands.
Roberto García-Díaz   +16 more
doaj   +2 more sources

Identification and Characterization of a Phenyl(trifluoro-methyl)-pyrimidine Positive Allosteric Modulator of the Secretin Receptor [PDF]

open access: yesMembranes
G protein-coupled receptors (GPCRs) are among the most common drug targets, with numerous agonists and antagonists approved for clinical use. More recently, it has been appreciated that drugs can also modulate the action of natural agonists of these ...
Kaleeckal G. Harikumar   +5 more
doaj   +2 more sources

The binding and mechanism of a positive allosteric modulator of Kv3 channels [PDF]

open access: yesNature Communications
Small-molecule modulators of diverse voltage-gated K+ (Kv) channels may help treat a wide range of neurological disorders. However, developing effective modulators requires understanding of their mechanism of action.
Qiansheng Liang   +11 more
doaj   +2 more sources

Gestodene, a novel positive allosteric modulator of PAR1, enhances PAR1-mediated human platelet aggregation [PDF]

open access: yesFrontiers in Pharmacology
Background: Protease-activated receptor 1 (PAR1) is expressed in human platelets and can be activated by low concentrations of thrombin. Vorapaxar, a selective antagonist of PAR1, inhibits thrombin-induced calcium mobilization in human platelet, which is
So-Hyeon Park   +9 more
doaj   +2 more sources

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

open access: yesMolecules, 2023
Positive allosteric modulators (PAMs), negative allosteric modulators (NAMs), silent agonists, allosteric activating PAMs and neutral or silent allosteric modulators are compounds capable of modulating the nicotinic receptor by interacting at allosteric ...
Dina Manetti   +6 more
doaj   +1 more source

The allosterically modulated FFAR2 is transactivated by signals generated by other neutrophil GPCRs.

open access: yesPLoS ONE, 2023
Positive allosteric modulators for free fatty acid receptor 2 (FFAR2/GPR43), that affect receptor function through binding to two distinct allosteric binding sites, were used to determine the correlation between the responses induced in neutrophils by ...
Simon Lind   +3 more
doaj   +2 more sources

Prospects for the use of allosteric drugs in real-world clinical practice

open access: yesРеальная клиническая практика: данные и доказательства, 2023
While the clinical validity of the use of allosteric regulation is known, scientists are working on the discovery of new methods for the development of allosteric drugs that can modulate the functions of enzymes, depending on the desired therapeutic ...
I. R. Svechkareva, A. S. Kolbin
doaj   +1 more source

Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2

open access: yeseLife, 2022
Activation of G protein-coupled receptors (GPCRs) is an allosteric process. It involves conformational coupling between the orthosteric ligand binding site and the G protein binding site. Factors that bind at non-cognate ligand binding sites to alter the
Brandon Wey-Hung Liauw   +5 more
doaj   +1 more source

The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site

open access: yesToxins, 2021
α-conotoxins are 13–19 amino acid toxin peptides that bind various nicotinic acetylcholine receptor (nAChR) subtypes. α-conotoxin Mr1.7c (MrIC) is a 17 amino acid peptide that targets α7 nAChR.
Alican Gulsevin   +6 more
doaj   +1 more source

Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics

open access: yesPharmaceuticals, 2020
Schizophrenia was first described by Emil Krapelin in the 19th century as one of the major mental illnesses causing disability worldwide. Since the introduction of chlorpromazine in 1952, strategies aimed at modifying the activity of dopamine receptors ...
Irene Fasciani   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy